CAPTRUST Financial Advisors’s CRISPR Therapeutics CRSP Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$878K Sell
18,057
-662
-4% -$32.2K ﹤0.01% 1425
2025
Q1
$637K Sell
18,719
-9,851
-34% -$335K ﹤0.01% 1509
2024
Q4
$1.12M Sell
28,570
-3,142
-10% -$124K ﹤0.01% 1168
2024
Q3
$1.49M Buy
31,712
+7,688
+32% +$361K ﹤0.01% 979
2024
Q2
$1.3M Sell
24,024
-1,419
-6% -$76.6K ﹤0.01% 1010
2024
Q1
$1.73M Sell
25,443
-1,247
-5% -$85K 0.01% 865
2023
Q4
$1.67M Buy
26,690
+2,881
+12% +$180K 0.01% 990
2023
Q3
$1.08M Sell
23,809
-428
-2% -$19.4K ﹤0.01% 1165
2023
Q2
$1.36M Sell
24,237
-1,719
-7% -$96.5K 0.01% 1014
2023
Q1
$1.17M Sell
25,956
-256
-1% -$11.6K 0.01% 953
2022
Q4
$1.07M Buy
26,212
+701
+3% +$28.5K 0.01% 937
2022
Q3
$1.67M Buy
25,511
+1,727
+7% +$113K 0.01% 736
2022
Q2
$1.45M Buy
23,784
+2,800
+13% +$170K 0.01% 702
2022
Q1
$1.32M Sell
20,984
-4,000
-16% -$251K 0.01% 738
2021
Q4
$1.89M Buy
24,984
+7,518
+43% +$570K 0.01% 578
2021
Q3
$1.96M Sell
17,466
-3,773
-18% -$422K 0.02% 527
2021
Q2
$3.44M Sell
21,239
-811
-4% -$131K 0.03% 366
2021
Q1
$2.69M Buy
22,050
+4,797
+28% +$585K 0.03% 398
2020
Q4
$2.64M Sell
17,253
-225
-1% -$34.5K 0.04% 359
2020
Q3
$1.46M Sell
17,478
-1,747
-9% -$146K 0.02% 399
2020
Q2
$1.51M Buy
19,225
+711
+4% +$55.8K 0.02% 408
2020
Q1
$713K Buy
18,514
+3,775
+26% +$145K 0.02% 497
2019
Q4
$874K Buy
14,739
+13,739
+1,374% +$815K 0.01% 535
2019
Q3
$41K Hold
1,000
﹤0.01% 1056
2019
Q2
$47K Hold
1,000
﹤0.01% 985
2019
Q1
$36K Buy
+1,000
New +$36K ﹤0.01% 994
2018
Q3
Sell
-81
Closed -$5K 1587
2018
Q2
$5K Buy
+81
New +$5K ﹤0.01% 1322